Early ID of Postpartum Hemorrhage Helpful in Vaginal Delivery
FRIDAY, May 12, 2023 (HealthDay News) -- For patients having a vaginal delivery, early detection of postpartum hemorrhage and use of bundled treatment leads to a reduction in a composite of severe postpartum hemorrhage, laparotomy for bleeding, or death from bleeding, according to a study published online May 9 in the New England Journal of Medicine. The research was published to coincide with the International Maternal Newborn Health Conference, held from May 8 to 11 in Cape Town, South Africa.
Ioannis Gallos, M.D., from the World Health Organization in Geneva, Switzerland, and colleagues conducted an international, cluster-randomized trial to assess a multicomponent clinical intervention, including a calibrated blood-collection drape for early detection of postpartum hemorrhage and a bundle of first-response treatments supported by an implementation strategy, in patients undergoing vaginal delivery. Eighty secondary-level hospitals across Kenya, Nigeria, South Africa, and Tanzania, with 210,132 patients undergoing vaginal delivery, were randomly assigned to intervention or usual care.
The researchers found that a primary outcome event (composite of severe postpartum hemorrhage, laparotomy for bleeding, or maternal death from bleeding) occurred in 1.6 and 4.3 percent of patients in the intervention and usual care groups, respectively (risk ratio, 0.40). Postpartum hemorrhage was detected in 93.1 and 51.1 percent of patients in the intervention and usual care groups, respectively (rate ratio, 1.58); the treatment bundle was used in 91.2 and 19.4 percent, respectively (rate ratio, 4.94).
"The E-MOTIVE intervention resulted in a 60 percent lower risk of the primary outcome," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Could COVID Trigger ‘Face Blindness’?
THURSDAY, March 16, 2023 (HealthDay News) -- The list of symptoms that can...
Meses tras una nueva norma, más de la mitad de los hospitales de EE. UU. no publican sus precios en línea
LUNES, 13 de diciembre de 2021 (HealthDay News) -- Para muchos estadounidenses,...
Johnson & Johnson Seeks FDA Emergency Approval for Its Booster Shot
TUESDAY, Oct. 5, 2021 (HealthDay News) -- Johnson & Johnson announced...
Un marcador de una prueba sanguínea podría medir los riesgos tras la cirugía cardiaca
JUEVES, 3 de marzo de 2022 (HealthDay News) -- Cada año, alrededor de 2 millones...